[1] [2] The frequency of monitoring should be determined by the prescribing clinician based on individual patient factors
The reduced risk was consistent when studying only patients with Type 2 diabetes (RR 0.54) or patients without diabetes (RR 0.52)
F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., Lei, H
If gastrointestinal discomfort (including bloating, cramps, diarrhea, or other digestive upset) or other sensitivity is experienced stop taking the product immediately
Dr Pellegrino is one of the best doctors I've ever had
A meta-analysis of RCTs and cohort studies showed that SGLT2 inhibitors reduce the risk of AKI across diverse cardiovascular risk profiles [59,109], and are associated with lower mortality, major adverse kidney events, and MACE in acute kidney disease [110]